Glaukos Corp - ESG Rating & Company Profile powered by AI
This Disclosure rating includes 17 UN Sustainable Development Goals including: 'Zero Hunger', 'Sustainable Cities & Communities' and 'Life below Water'. The dashboard contains a questions and answers section for Glaukos Corp. Browse to the end of this webpage for potential risks for Glaukos Corp based on industry, geography and size.
Glaukos Corp in the Medical Equipment, Supplies & Distribution industry gained a UN SDG ESG Transparency Score of 7.6; made up of an environmental score of 8.0, social score of 6.9 and governance score of 8.0.
7.6
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Bioteque Corp | 8.0 | High |
| 1 | Amplitude Surgical SA | 8.0 | High |
| 35 | DENTSPLY SIRONA Inc | 7.7 | High |
| 35 | Smith & Nephew PLC | 7.7 | High |
| 37 | Glaukos Corp | 7.6 | High |
| 37 | ConvaTec Group PLC | 7.6 | High |
| 37 | Hill-Rom Holdings Inc | 7.6 | High |
| ... | ... | ... | |
| 380 | ZoomMed Inc | 0.0 | Low |
| 380 | iRay Technology Co Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Glaukos Corp have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Glaukos Corp disclose current and historical energy intensity?
Sign up for free to unlockDoes Glaukos Corp report the average age of the workforce?
Sign up for free to unlockDoes Glaukos Corp reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Glaukos Corp disclose its ethnicity pay gap?
Sign up for free to unlockDoes Glaukos Corp disclose cybersecurity risks?
Sign up for free to unlockDoes Glaukos Corp offer flexible work?
Sign up for free to unlockDoes Glaukos Corp have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Glaukos Corp disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Glaukos Corp conduct supply chain audits?
Sign up for free to unlockDoes Glaukos Corp disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Glaukos Corp conduct 360 degree staff reviews?
Sign up for free to unlockDoes Glaukos Corp disclose the individual responsible for D&I?
Sign up for free to unlockDoes Glaukos Corp disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Glaukos Corp disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Glaukos Corp disclose water use targets?
Sign up for free to unlockDoes Glaukos Corp have careers partnerships with academic institutions?
Sign up for free to unlockDid Glaukos Corp have a product recall in the last two years?
Sign up for free to unlockDoes Glaukos Corp disclose incidents of discrimination?
Sign up for free to unlockDoes Glaukos Corp allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Glaukos Corp issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Glaukos Corp disclose parental leave metrics?
Sign up for free to unlockDoes Glaukos Corp disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Glaukos Corp disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Glaukos Corp disclose the pay ratio of women to men?
Sign up for free to unlockDoes Glaukos Corp support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Glaukos Corp disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Glaukos Corp reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Glaukos Corp involved in embryonic stem cell research?
Sign up for free to unlockDoes Glaukos Corp disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Glaukos Corp disclose its waste policy?
Sign up for free to unlockDoes Glaukos Corp report according to TCFD requirements?
Sign up for free to unlockDoes Glaukos Corp disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Glaukos Corp disclose energy use targets?
Sign up for free to unlockDoes Glaukos Corp disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Glaukos Corp have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Glaukos Corp
These potential risks are based on the size, segment and geographies of the company.
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite, a three stents product that is designed for use as a standalone procedure in patients with refractory glaucoma; and iDose TR, a targeted injectable implant based on its micro-scale device-platform that is designed to deliver therapeutic levels of medication. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in San Clemente, California.